Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais, +1432

The Lancet

Metabolic SyndromeDiabetes ManagementCardiovascular DiseaseHealth PolicyCardiovascular Outcomes +7

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais, +1434

The Lancet

Metabolic SyndromeDiabetes ManagementUrologyChronic Kidney DiseaseDiabetes +8

p300 and p300/cAMP-response Element-binding Protein-associated Factor Acetylate the Androgen Receptor at Sites Governing Hormone-dependent Transactivation

Maofu Fu, Chenguang Wang, Anne T. Reutens, +6

Journal of Biological Chemistry

Direct Acetylation of the Estrogen Receptor α Hinge Region by p300 Regulates Transactivation and Hormone Sensitivity

Chenguang Wang, Maofu Fu, Ruth Hogue Angeletti, +11

Journal of Biological Chemistry

Activation of the cyclin D1 Gene by the E1A-associated Protein p300 through AP-1 Inhibits Cellular Apoptosis

Chris Albanese, Mark D’Amico, Anne T. Reutens, +9

Journal of Biological Chemistry

Cyclin D1 Binds the Androgen Receptor and Regulates Hormone-Dependent Signaling in a p300/CBP-Associated Factor (P/CAF)-Dependent Manner

Anne T. Reutens, Maofu Fu, Chenguang Wang, +7

Molecular Endocrinology

P300/cbp-associated FactorAndrogen ReceptorSystems BiologyMolecular PhysiologySignal Transduction +13

Sulodexide Fails to Demonstrate Renoprotection in Overt Type 2 Diabetic Nephropathy

David Packham, Rory Wolfe, Anne T. Reutens, +11

Journal of the American Society of Nephrology

Renal PathologyOxidative StressGlomerulonephritisRenal FunctionDemonstrate Renoprotection +19

Inhibition of Cyclin D1 Kinase Activity Is Associated with E2F-Mediated Inhibition of Cyclin D1 Promoter Activity through E2F and Sp1

Genichi Watanabe, Chris Albanese, Richard J. Lee, +4

Molecular and Cellular Biology

Clinical and Functional Effects of Mutations in the<i>DAX-1</i>Gene in Patients with Adrenal Hypoplasia Congenita¹

Anne T. Reutens, John C. Achermann, Masafumi Ito, +7

The Journal of Clinical Endocrinology & Metabolism

Adrenal Hypoplasia CongenitaAdrenal GlandDevelopmental BiologyMendelian DisorderGenetic Disorder +13

Pyridorin in Type 2 Diabetic Nephropathy

Edmund J. Lewis, Tom Greene, Samuel Spitalewiz, +13

Journal of the American Society of Nephrology

Molecular PharmacologyRenal FunctionVersus PlaceboChronic Kidney DiseaseRenal Pharmacology +15